Subcommittees:
* Energy and Commerce (113th Congress)
On Tuesday, May 6, 2014, at 3 PM, the committee will host thought leaders in the first public discussion regarding the state of biomedical innovation in the United States and what else can be done to accelerate the process of bringing new treatments and cures to patients. Participants will include:
Participants
Dr. Francis Collins
Director of the National Institutes of Health
Dr. Janet Woodcock
Director of FDA’s Center for Drug Evaluation and Research
Dr. Jeff Shuren
Director of FDA’s Center for Devices and Radiological Health
Margaret Anderson
Executive Director of FasterCures
Dr. James Woolliscroft
Dean of the University of Michigan Medical School
Dr. Joe Gray
Associate Director for Translational Research, Knight Cancer Institute, Oregon Health and Science University
Dr. Andrew von Eschenbach
President of Samaritan Health Initiatives Inc.
Chairman of Project FDA at the Manhattan Institute
Dr. Peter Huber
Senior Fellow at the Manhattan Institute
Dr. Ellen Sigal
Chairperson and Founder of Friends of Cancer Research
Sarah Despres
Pew Charitable Trusts
Jonathan Leff
Partner at Deerfield Management
Chairman of the Deerfield Institute
Learn more about 21st Century Cures online here, join the effort on Facebook and Twitter, and contribute to the conversation using #Path2Cures
Opening Statement of Energy and Commerce Committee Chairman Fred Upton
